ANTIHYPERLIPIDEMIC ACTIVITY OF CASSIA FISTULA BARK USING HIGH FAT DIET INDUCED HYPERLIPIDEMIA
Keywords:
Antihyperlipidemic, Antiatherosclerotic, Cassia fistula, CaesalpiniaceaeAbstract
Objective: To study the antihyperlipidemic and anti atherosclerotic activity of Cassia fistula extracts in experimentally induced atherosclerotic rats.
Methods: In this study, the antihyperlipidemic activity of Cassia fistula bark was evaluated by the administration of high fat diet. Atherosclerosis was induced in wistar rats by feeding with high cholesterol diet for 21 d. Oral feeding of cholesterol (500 mg/kg b.w./day) dissolved in coconut oil (0.5 ml/rat/day) caused an elevation in total cholesterol, LDL cholesterol, VLDL cholesterol triglycerides serum of rats.
Results: Administration of Cassia fistula extracts (methanolic and ethyl acetate extract at 500 mg/kg respectively) along with high cholesterol diet reduced the raised serum level of total cholesterol, triglyceride, LDL, VLDL and increased the serum HDL level as compared to the control group (High cholesterol group). Histopathology study of heart has shown decrease in myocardial degeneration and inflammation which may be attributed to the anti atherosclerotic activity of the Cassis fistula bark extracts.
Conclusion: These results suggested that Cassia fistula bark possess significant antihyperlipidemic activity.
Â
Downloads
References
Ankur R, Nidhi D, Seema R, Amarjeet D, Ashok K. Hyperlipidemia-a deadly pathological condition. Int J Curr Pharm Res 2012;4:15-8.
Brahma RD, Saileela CH. Anti-hyperlipidemic activity of methanolic extract of Rhinacanthus nasutus. Int J Res Pharm Chem 2013;3:708-11.
Bidkar JS, Ghanwat DD, Dama GY, Bhujbal M D, Shende V S. A global review on plants with hypolipidemic activity. Deccan J Pharma 2011;2:0976-139X.
Dhaliya SA, Surya AS, Dawn VT, Betty C, Arun K, Dr. Sunil C. A review of hyperlipidemia and medicinal plants. Int J Pharm Sci Bio Med Sci2013;2:219-37.
Uttam CG and Jain GC. Study on Hypolipidemic Activity of Cassia fistula legume in Rats. Asian J Exp Sci 2009;23:241-8.
Istvan ES and Deisenhofer J. The structure of the catalytic portion of human HMG-CoA reductase. Biochem Biophys Acta 2005;15:9-18.
Kleemann R and Kooistra T. HMG-CoA reductase inhibitors: effects on chronic sub acute inflammation and onset of atherosclerosis induced by dietary cholesterol. Curr Drug Targets Cardiovas Haemat Disord 2005;5:441-53.
Marshall WJ. Lipids and Lipoproteins. In: Illustrated Text Book of Clinical Chemistry, 2nd ed. Gower Medical Publishing, London. 1992:p222–37.
Stone NJ. Secondary causes of hyperlipidemia. Med Clin North Am 1994;78:117-141.
Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
Ellman GL. Tissue sulfhydryl groups. Arch Biochem Biophys 1959;82:70-7.
Misra HP, Fridovich I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J Biol Chem 1972;247:3170-5.
Mohana T, Navin AV, Jayachandaran KS, Sivasitambaram ND. Protective effect of grape seed proanthocyanidins against cholesterol cholic acid diet-induced hypercholesterolemia in rats. Cardiovas Pathol 2011;20:361–8.
Venugopal A and Ramarishna S. Indirect assessment of Hydroxymethylglutaryl-CoA reductase (NADPH) activity in liver. Clin Chem 2005;21:1523-5.
Nofer JR, Kehrel B, Fobker M, Levkau B, Assmann G, Eckardstein AV. HDL and atherosclerosis beyond reverse cholesterol transport. Atherosclerosis 2002;6:1-16.